Grant A. Mitchell
Centre Hospitalier Universitaire Sainte-Justine · 244 works · 17,416 citations · h-index 66
Top works
- Adipocyte death defines macrophage localization and function in adipose tissue of obese mice and humans
- Identification of a gene causing human cytochrome c oxidase deficiency by integrative genomics
- A combined syndrome of juvenile polyposis and hereditary haemorrhagic telangiectasia associated with mutations in MADH4 ( SMAD4)
- Alu sequences in the coding regions of mRNA: a source of protein variability
- Strand-separating conformational polymorphism analysis: Efficacy of detection of point mutations in the human ornithine δ-aminotransferase gene
- The Adipose Tissue Phenotype of Hormone‐Sensitive Lipase Deficiency in Mice
- Neurologic Crises in Hereditary Tyrosinemia
- At least two mutant alleles of ornithine delta-aminotransferase cause gyrate atrophy of the choroid and retina in Finns.
- Excess of De Novo Deleterious Mutations in Genes Associated with Glutamatergic Systems in Nonsyndromic Intellectual Disability
- Medical aspects of ketone body metabolism.
- Splice-mediated insertion of an Alu sequence inactivates ornithine delta-aminotransferase: a role for Alu elements in human mutation.
- Hepatic and Muscular Presentations of Carnitine Palmitoyl Transferase Deficiency: Two Distinct Entities
- Human ornithine-delta-aminotransferase. cDNA cloning and analysis of the structural gene.
- Ornithine delta-aminotransferase mutations in gyrate atrophy. Allelic heterogeneity and functional consequences.
- Pathways and control of ketone body metabolism: on the fringe of lipid biochemistry
- The succinate receptor GPR91 in neurons has a major role in retinal angiogenesis
- A Missense Mutation (R565W) in Cirhin (FLJ14728) in North American Indian Childhood Cirrhosis
- Selection against lethal alleles in females heterozygous for incontinentia pigmenti.
- Hyperornithinaemia- hyperammonaemia- homocitrullinuria syndrome is caused by mutations in a gene encoding a mitochondrial ornithine transporter
- Recommendations for the management of tyrosinaemia type 1